CREDITRISKMONITOR COM INC, 10-Q filed on 19 Aug 26
v3.26.1
Document And Entity Information - shares
6 Months Ended
Jun. 30, 2026
Aug. 19, 2026
Document Information Line Items    
Entity Central Index Key 0000315958  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2026  
Document Fiscal Year Focus 2026  
Document Transition Report false  
Entity File Number 1-8601  
Entity Registrant Name CreditRiskMonitor.com, Inc.  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 36-2972588  
City Area Code 845  
Local Phone Number 230-3000  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   10,767,501
Amendment Flag false  
Document Fiscal Period Focus Q2  
Current Fiscal Year End Date --12-31  
v3.26.1
CONDENSED BALANCE SHEETS - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 9,337,275 $ 6,248,223
Held-to-maturity securities 8,498,606 10,618,881
Accounts receivable, net of allowance for credit losses of $30,000 3,642,532 3,786,681
Other current assets 920,125 1,131,686
Total current assets 22,398,538 21,785,471
Held-to-maturity securities 971,000 1,997,000
Property and equipment, net 390,963 415,859
Operating lease right-of-use asset, net 68,732 84,525
Goodwill 1,954,460 1,954,460
Deferred tax assets, net 58,709 58,709
Total assets 25,842,402 26,296,024
Current liabilities:    
Unexpired subscription revenue 11,244,709 10,933,761
Accounts payable 193,509 169,988
Operating lease liability 30,363 29,364
Accrued expenses 3,806,121 4,067,617
Total current liabilities 15,274,702 15,200,730
Unexpired subscription revenue, less current portion 132,629 178,936
Operating lease liability, less current portion 38,369 55,161
Total liabilities 15,445,700 15,434,827
Stockholders’ equity:    
Preferred stock, $.01 par value; authorized 5,000,000 shares; none issued 0 0
Common stock, $.01 par value; authorized 32,500,000 shares; issued and outstanding 10,767,501 shares 107,675 107,675
Additional paid-in capital 30,363,313 30,300,696
Accumulated deficit (20,074,286) (19,547,174)
Total stockholders’ equity 10,396,702 10,861,197
Total liabilities and stockholders’ equity $ 25,842,402 $ 26,296,024
v3.26.1
CONDENSED BALANCE SHEETS (Parentheticals) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
CONDENSED BALANCE SHEETS [Abstract]    
Accounts receivable, allowance for credit losses $ 30,000 $ 30,000
Preferred stock, par value (in Dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized (in Shares) 5,000,000 5,000,000
Preferred stock, issued (in Shares) 0 0
Common stock, par value (in Dollars per share) $ 0.01 $ 0.01
Common stock, authorized (in Shares) 32,500,000 32,500,000
Common stock, issued (in Shares) 10,767,501 10,767,501
Common stock, outstanding (in Shares) 10,767,501 10,767,501
v3.26.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
CONDENSED STATEMENTS OF OPERATIONS [Abstract]        
Operating revenues $ 5,166,174 $ 5,059,542 $ 10,153,052 $ 9,930,955
Operating expenses:        
Data and product costs 2,733,543 2,194,060 5,254,448 4,477,434
Selling, general and administrative expenses 3,044,796 2,756,881 5,672,433 5,370,427
Depreciation and amortization 51,782 117,044 105,602 202,764
Total operating expenses 5,830,121 5,067,985 11,032,483 10,050,625
Loss from operations (663,947) (8,443) (879,431) (119,670)
Other income, net 139,034 153,798 279,708 311,664
(Loss) income before income taxes (524,913) 145,355 (599,723) 191,994
Benefit (provision) for income taxes 50,124 (9,914) 72,611 (64,362)
Net (loss) income $ (474,789) $ 135,441 $ (527,112) $ 127,632
Net (loss) income per share - Basic (in Dollars per share) $ (0.04) $ 0.01 $ (0.05) $ 0.01
Net (loss) income per share - diluted (in Dollars per share) $ (0.04) $ 0.01 $ (0.05) $ 0.01
Weighted average number of common shares outstanding        
Basic (in Shares) 10,767,501 10,767,501 10,767,501 10,744,826
Diluted (in Shares) 10,767,501 10,853,074 10,767,501 10,843,170
v3.26.1
CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2024 $ 107,224 $ 30,106,731 $ (20,058,335) $ 10,155,620
Balance (in Shares) at Dec. 31, 2024 10,722,401      
Stock options exercised $ 451 96,484 0 96,935
Stock options exercised (in Shares) 45,100      
Net income (loss) $ 0 0 127,632 127,632
Stock-based compensation 0 50,468 0 50,468
Balance at Jun. 30, 2025 $ 107,675 30,253,683 (19,930,703) 10,430,655
Balance (in Shares) at Jun. 30, 2025 10,767,501      
Balance at Mar. 31, 2025 $ 107,224 30,134,016 (20,066,144) 10,175,096
Balance (in Shares) at Mar. 31, 2025 10,722,401      
Stock options exercised $ 451 96,484 0 96,935
Stock options exercised (in Shares) 45,100      
Net income (loss) $ 0 0 135,441 135,441
Stock-based compensation 0 23,183 0 23,183
Balance at Jun. 30, 2025 $ 107,675 30,253,683 (19,930,703) 10,430,655
Balance (in Shares) at Jun. 30, 2025 10,767,501      
Balance at Dec. 31, 2025 $ 107,675 30,300,696 (19,547,174) $ 10,861,197
Balance (in Shares) at Dec. 31, 2025 10,767,501     10,767,501
Net income (loss) $ 0 0 (527,112) $ (527,112)
Stock-based compensation 0 62,617 0 62,617
Balance at Jun. 30, 2026 $ 107,675 30,363,313 (20,074,286) $ 10,396,702
Balance (in Shares) at Jun. 30, 2026 10,767,501     10,767,501
Balance at Mar. 31, 2026 $ 107,675 30,326,362 (19,599,497) $ 10,834,540
Balance (in Shares) at Mar. 31, 2026 10,767,501      
Net income (loss) $ 0 0 (474,789) (474,789)
Stock-based compensation 0 36,951 0 36,951
Balance at Jun. 30, 2026 $ 107,675 $ 30,363,313 $ (20,074,286) $ 10,396,702
Balance (in Shares) at Jun. 30, 2026 10,767,501     10,767,501
v3.26.1
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net (loss) income $ (527,112) $ 127,632
Adjustments to reconcile net income to net cash used by operating activities:    
Amortization of bond discount (61,724) (94,066)
Depreciation and amortization 105,602 202,764
Stock-based compensation 62,617 50,468
Changes in operating assets and liabilities:    
Accounts receivable, net 144,149 (1,083,584)
Other current assets 211,561 20,879
Unexpired subscription revenue 264,641 1,041,958
Accounts payable 23,521 (100,407)
Accrued expenses (261,496) (2,677)
Net cash (used in) provided by operating activities (38,241) 162,967
Cash flows from investing activities:    
Proceeds from held-to-maturity securities 3,208,000 1,995,000
Purchase of held-to-maturity securities 0 (2,936,262)
Purchase of property and equipment (80,707) (214,231)
Net cash provided by (used in) investing activities 3,127,293 (1,155,493)
Cash flows from financing activities:    
Proceeds from exercise of stock options 0 96,935
Net cash provided by financing activities 0 96,935
Net increase (decrease) in cash and cash equivalents 3,089,052 (895,591)
Cash and cash equivalents at beginning of period 6,248,223 6,674,473
Cash and cash equivalents at end of period $ 9,337,275 $ 5,778,882
v3.26.1
Overview and Basis of Presentation
6 Months Ended
Jun. 30, 2026
Overview and Basis of Presentation [Abstract]  
Overview and Basis of Presentation
(1) Overview and Basis of Presentation
 
CreditRiskMonitor.com, Inc. (the “Company” or “CreditRiskMonitor.com”) provides interactive business-to-business Software-as-a-Service (“SaaS”) subscription products designed specifically for credit and supply chain risk managers. These products are sold predominantly to corporations located in the United States.
 
The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures required by generally accepted accounting principles (“GAAP”) in the United States for complete financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, the accompanying unaudited condensed financial statements reflect all material adjustments, including normal recurring accruals, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods presented, and have been prepared in a manner consistent with the audited financial statements for the fiscal year ended December 31, 2025.
 
The results of operations for the three and six months ended June 30, 2026 and 2025 are not necessarily indicative of the results for an entire fiscal year.
 
The December 31, 2025 condensed balance sheet has been derived from the audited financial statements at that date, but does not include all disclosures required by GAAP for complete financial statements. These condensed financial statements should be read in conjunction with the audited financial statements and the footnotes for the fiscal year ended December 31, 2025 included in the Company’s Annual Report on Form 10-K/A.
v3.26.1
Restatement of Previously Issued Financial Statements
6 Months Ended
Jun. 30, 2026
Restatement of Previously Issued Financial Statements [Abstract]  
Restatement of Previously Issued Financial Statements
(2) Restatement of Previously Issued Financial Statements
 
In connection with a nexus study conducted with an external tax advisor, the Company’s management identified errors in previously issued financial statements. Management prepared a quantitative and qualitative analysis of the errors described below, in accordance with the SEC Staff's Accounting Bulletin ("SAB") Nos. 99 Materiality and No. 108, Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, and concluded the aggregate impact of all the errors is material to the Company's previously reported financial statements as of and for the three and six months ended June 30, 2025. As a result, the Company’s management and the Audit Committee of the Company’s Board of Directors concluded that it is appropriate to restate the Company’s previously issued unaudited condensed financial statements as of and for the three and six months ended June 30, 2025, as previously reported in its Form 10-Q.
 
The accompanying condensed financial statements as of and for the three and six months ended June 30, 2025 have been restated from amounts previously reported. The restated classification and reported values of the errors noted from the nexus study are included in the condensed financial statements herein. The Company has also restated related amounts within the accompanying footnotes to the condensed financial statements to conform to the corrected amounts in the condensed financial statements.
 
Description of Restatement Errors
 
Based on a nexus study, the Company determined that it had economic and physical nexus in state and local jurisdictions where it historically had not been collecting and remitting sales and use tax and filing income taxes. As a result, the Company concluded that it had a historical state sales and use tax liability and income tax liability related to prior periods. The Company subsequently pursued Voluntary Disclosure Agreements (“VDAs”) to address this liability and to mitigate future exposure based on counsel of its tax advisor.
 
The liability includes an estimate for each state, to account for any interest that is due on the base tax amount owed. The error resulted in an understatement of accrued expenses for state and local sales tax and income tax, including related interest in the previously issued financial statements as of and for the three and six months ended June 30, 2025. As a result of correcting this liability, selling, general and administrative expenses; income tax expense; and interest expense were increased in the affected periods. The underlying sales tax obligations are appropriately recognized and the Company is in various stages of VDA review, submission, acceptance and payment with the states impacted. The Company has subsequently engaged an independent third-party provider of automated sales tax solutions to support with compliance through continuous identification, monitoring and evaluation of our transaction activity and physical presence.
Financial Statements - Restatement Reconciliation Tables
 
In accordance with Accounting Standards Codification ("ASC") 250, Accounting Changes and Error Corrections, the Company has corrected this error by restating previously issued financial statements.
 
The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the periods indicated. The amounts in the "As Restated" columns are the updated amounts including the impacts from the restatement. Financial statement line items and subtotals that were not impacted by the restatement adjustments have been omitted for enhanced clarity.
 
Balance Sheet – as of December 31, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Deferred tax assets, net
 $-    $58,709   $58,709 
Total assets
  26,237,315    58,709    26,296,024 
                
Accrued expenses
  2,160,366    1,907,251    4,067,617 
Total current liabilities
  13,293,479    1,907,251    15,200,730 
Deferred tax liabilities, net
  355,646    (355,646    -  
Total liabilities
  13,883,222    1,551,605    15,434,827 
                
Accumulated deficit
  (18,054,278   (1,492,896   (19,547,174
Total stockholders’ equity
 $12,354,093   $(1,492,896  $10,861,197 
 
Statement of Operations – Three Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Selling, general, and administrative expenses  $2,627,168   $129,713   $2,756,881 
Total operating expenses   4,938,272    129,713    5,067,985 
Income from operations   121,270    (129,713   (8,443
Other income, net   179,684    (25,886   153,798 
Income before income taxes   300,954    (155,599   145,355 
Provision for income taxes   (71,427   61,513    (9,914
Net income   229,527    (94,086   135,441 
                
Net income per share – Basic and diluted  $0.02    (0.01  $0.01 
Statement of Operations - Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Selling, general, and administrative expenses
 $5,104,119   $266,308   $5,370,427 
Total operating expenses
  9,784,317    266,308    10,050,625 
Income from operations
  146,638    (266,308   (119,670
Other income, net
  360,516    (48,852   311,664 
Income before income taxes
  507,154    (315,160   191,994 
Provision for income taxes
  (118,565   54,203    (64,362
Net income
  388,589    (260,957   127,632 
                
Net income per share – Basic and diluted
 $0.04   $(0.03  $0.01 
 
Statements of Stockholders' Equity – Three Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Balance as of April 1, 2025
              
Accumulated deficit
 $(18,913,147  $(1,152,997  $(20,066,144
Total stockholders’ equity
  11,328,093    (1,152,997   10,175,096 
                
Balance as of June 30, 2025
              
Accumulated deficit
  (18,683,620   (1,247,083   (19,930,703
Total stockholders’ equity
 $11,677,738   $(1,247,083  $10,430,655 
 
Statements of Stockholders' Equity – Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Balance as of January 1, 2025
              
Accumulated deficit
 $(19,072,209  $(986,126  $(20,058,335
Total stockholders’ equity
  11,141,746    (986,126   10,155,620 
                
Balance as of June 30, 2025
              
Accumulated deficit
  (18,683,620   (1,247,083   (19,930,703
Total stockholders’ equity
 $11,677,738   $(1,247,083  $10,430,655 
 
No other components of stockholders' equity, including preferred stock, common stock and additional paid-in capital, were affected by this restatement.
 
Statement of Cash Flows –Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Six Months Ended June 30, 2025
              
Cash flows from operating activities:
              
Net income
 $388,589   $(260,957  $127,632 
Changes in operating assets and liabilities:
              
Accrued expenses
 $(263,634  $260,957   $(2,677
 
The restatement had no effect on the total cash flows from operations, investing activities, or financing activities of the Company.
v3.26.1
Recently Issued Accounting Standards
6 Months Ended
Jun. 30, 2026
Recently Issued Accounting Standards [Abstract]  
Recently Issued Accounting Standards
(3) Recently Issued Accounting Standards
 
In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which provides for improvements to income tax disclosures primarily related to rate reconciliation and income taxes paid by jurisdiction. The Company adopted ASU 2023-09 on a prospective basis effective January 1, 2025 and the adoption of this update did not have a significant impact on the Company’s financial statements.
 
In November 2024, the FASB issued ASU 2024-03, Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”), to improve disclosures about a public entity’s expenses by requiring disclosure of additional information about the types of expenses commonly presented in the financial statements on an annual and interim basis. This guidance will be effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact of adoption of this pronouncement on its financial statements.
v3.26.1
Revenue Recognition
6 Months Ended
Jun. 30, 2026
Revenue Recognition [Abstract]  
Revenue Recognition
(4) Revenue Recognition
 
The Company applies FASB Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers (Topic 606) (“ASC 606”), to recognize revenue. ASC 606 requires an entity to apply the following five-step approach: (1) identify the contract(s) with a customer; (2) identify each performance obligation in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation; and (5) recognize revenue when or as each performance obligation is satisfied. The Company’s primary source of revenue is subscription income which is recognized ratably over the subscription term.
v3.26.1
Stockholders’ Equity
6 Months Ended
Jun. 30, 2026
Stockholders’ Equity [Abstract]  
Stockholders’ Equity
(5) Stockholders’ Equity
 
Stock-Based Compensation
 
The Company applies ASC 718, CompensationStock Compensation (Topic 718) (“ASC 718”), to account for stock-based compensation.
 
The table below summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three and six months ended June 30, 2026 and 2025, respectively, as follows:
 
                     
 
3 Months Ended
June 30,
 
6 Months Ended
June 30,
 
    2026     2025     2026     2025  
                     
Data and product costs
 $12,017   $9,541   $21,336   $18,000 
Selling, general and administrative expenses
  24,934    13,642    41,281    32,468 
                     
   $36,951   $23,183   $62,617   $50,468 
 
Stock Options
 
There were no stock options exercised during the three and six months ended June 30, 2026.
 
On April 1, 2025, the Company issued 45,100 shares of common stock upon the exercise of stock options. The stock options had a weighted-average exercise price of $2.15 per share. The Company received cash proceeds totaling $96,935 in connection with the exercise of these stock options. The total intrinsic value of the stock options exercised during the three and six months ended June 30, 2025 was approximately $20,325.
v3.26.1
Fair Value Measurements
6 Months Ended
Jun. 30, 2026
Fair Value Measurements [Abstract]  
Fair Value Measurements
(6) Fair Value Measurements
 
The Company’s cash, cash equivalents and marketable securities are stated at amortized cost, which approximate fair value. The carrying values of accounts receivable, other current assets, accounts payable, and accrued expenses approximate fair market value because of the short maturity of these financial instruments.
 
The Company’s cash equivalents are generally classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.
 
All held-to-maturity securities as of June 30, 2026 and December 31, 2025 were U.S. Treasury securities. Investments in these government securities are based on quoted market prices in active markets, and are included in the Level 1 fair value hierarchy.
 
The tables below set forth the Company’s cash and cash equivalents, as well as marketable securities as of June 30, 2026 and December 31, 2025, respectively, which are measured at fair value on a recurring basis by level within the fair value hierarchy.
 
                     
 
June 30, 2026  
    Level 1     Level 2     Level 3     Total  
                     
Cash and cash equivalents
 $9,337,275   $   $   $9,337,275 
Held-to-maturity securities
  9,469,606            9,469,606 
   $18,806,881   $   $   $18,806,881 
 
                     
 
December 31, 2025  
    Level 1     Level 2     Level 3     Total  
                     
Cash and cash equivalents
 $6,248,223   $   $   $6,248,223 
Held-to-maturity securities
  12,615,881            12,615,881 
   $18,864,104   $   $   $18,864,104 
 
The Company did not hold financial assets and liabilities which were recorded at fair value in the Level 2 or 3 categories as of June 30, 2026 or December 31, 2025, respectively.
 
The preceding methods may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.
v3.26.1
Marketable Securities
6 Months Ended
Jun. 30, 2026
Marketable Securities [Abstract]  
Marketable Securities
(7) Marketable Securities
 
Based upon the Company’s intent and ability to hold its U.S. Treasury securities to maturity, such securities have been classified as held-to-maturity and are carried at amortized cost, which approximates fair market value. Maturities on these U.S. Treasury security holdings range from 19 to 25 months from the date of purchase. Accrued bond interest receivable as of June 30, 2026 and December 31, 2025 was $93,964 and $97,024, respectively, and is included in other current assets on the Condensed Balance Sheets.
The tables below summarize the Company’s cost and fair value of marketable securities as of June 30, 2026 and December 31, 2025, respectively, as follows:
 
                
 
June 30, 2026  
    Amortized Cost     Gross Unrealized Gain     Fair Value  
Held-to-maturity securities
              
U.S. Treasury securities
 $9,469,606   $11,394   $9,481,000 
 
                
 
December 31, 2025  
    Amortized Cost     Gross Unrealized Gain     Fair Value  
Held-to-maturity securities
              
U.S. Treasury securities
 $12,615,881   $73,119   $12,689,000 
 
Maturities of marketable securities as of June 30, 2026 and December 31, 2025, respectively, are as follows:
 
         
    June 30,
2026
    December 31,
2025
 
           
Held-to-maturity securities:
         
Due in one year or less
 $8,498,606   $10,618,881 
Due in 12 – 24 months
  971,000    1,997,000 
           
   $9,469,606   $12,615,881 
 
The Company’s investments in marketable securities consist of investments in U.S. Treasury securities. Market values were determined for each individual security in the investment portfolio.
 
Management evaluates securities for other-than-temporary impairment at least on an annual basis, and more frequently when economic or market concerns warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) the intent and ability of the Company to retain its investment in the issuer for a period of time sufficient to allow for any anticipated recovery in fair value. Management has determined that no other-than-temporary impairment exists as of June 30, 2026.
v3.26.1
Net Loss per Share
6 Months Ended
Jun. 30, 2026
Net Loss per Share [Abstract]  
Net Loss per Share
(8) Net Loss per Share
 
Basic net income per share is based on the weighted average number of common shares outstanding. Diluted net income per share is based on the weighted average number of common shares outstanding and the dilutive effect of outstanding stock options.
 
                     
 
3 Months Ended
June 30,
 
6 Months Ended
June 30,
 
    2026     2025     2026     2025  
                     
Weighted average common shares outstanding – basic
  10,767,501    10,767,501    10,767,501    10,744,826 
Potential shares exercisable under stock option plans
  -    311,673    -    312,731 
Less: Dilutive effect of outstanding stock option awards
  -    (226,100   -    (214,387
                     
Weighted average common shares outstanding – diluted
  10,767,501    10,853,074    10,767,501    10,843,170 
 
For the three and six months ended June 30, 2026, diluted net loss per share is the same as basic net loss per share because the effect of potential common shares was anti-dilutive due to the net loss reported for the period.
 
For the three and six months ended June 30, 2025, the computation of diluted net income per share excludes the effects of the assumed exercise of 501,450 and 500,450 options, respectively, since their inclusion would be anti-dilutive as their exercise prices were above the average market value.
v3.26.1
Commitments and Contingencies
6 Months Ended
Jun. 30, 2026
Commitments and Contingencies [Abstract]  
Commitments and Contingencies
(9) Commitments and Contingencies
 
From time to time, the Company is involved in various legal proceedings arising in the ordinary course of business. The Company records a liability when it believes that a loss will be incurred and the amount of loss or range of loss can be reasonably estimated. Based on the currently available information, the Company does not believe that there are claims or legal proceedings that would have a material adverse effect on the business, or the condensed financial statements of the Company.
v3.26.1
Segment Reporting
6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Reporting
(10) Segment Reporting
 
The Company has a single operating and reportable segment: SaaS subscription products. This segment includes add-ons and enhancements that can only be accessed with an active base subscription to its SaaS subscription products. The products are used mainly by subscribers to analyze commercial financial risk for the purpose of extending trade credit, evaluating supply chains, and managing the counterparty risk associated with these relationships.
 
The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer and President. The CODM makes operating decisions, assesses performance and allocates resources using the entity-wide revenue and expense information reported on the Condensed Statements of Operations and the more detailed significant expense categories disclosed in the table below. The primary measure of segment profit is net income as reported on the Condensed Statements of Operations.
 
                     
 
3 Months Ended
June 30,
 
6 Months Ended
June 30,
 
    2026

    2025
(As Restated)
    2026

    2025
(As Restated)
 
                     
Segment operating revenues
 $5,166,174   $5,059,542   $10,153,052   $9,930,955 
                     
Less: Significant segment expenses
                   
Data and product costs
                   
Employee expenses
  1,733,740    1,393,423    3,434,441    2,891,536 
Data feed expenses
  565,985    516,966    1,088,609    1,051,868 
Hosting and computer services expenses
  156,716    86,527    306,914    145,241 
Other data and product costs
  277,102    197,144    424,484    388,789 
Data and product costs subtotal
  2,733,543    2,194,060    5,254,448    4,477,434 
                     
Selling, general and administrative expenses
                   
Employee expenses
  1,858,260    1,932,924    3,727,046    3,847,035 
Professional fee expenses
  703,729    205,441    1,035,674    308,547 
Marketing expenses
  200,416    203,062    369,370    411,853 
Occupancy expenses (1)
  15,130    113,694    25,314    224,038 
Other general and administrative expenses
  267,261    301,760    515,029    578,954 
Selling, general and administrative expenses subtotal
  3,044,796    2,756,881    5,672,433    5,370,427 
                     
Other significant segment items
                   
Depreciation and amortization
  51,782    117,044    105,602    202,764 
Other (income), net
  (139,034   (153,798   (279,708   (311,664
(Benefit) provision for income taxes
  (50,124   9,914    (72,611   64,362 
                     
Segment net (loss) income
 $(474,789  $135,441   $(527,112  $127,632 
 
(1) Prior to the expiration of the Company’s leased office space on July 31, 2025, occupancy expenses included rent, utilities, repairs, and office supplies. Post expiration, occupancy expenses included the rental of virtual office space for Company meetings.
v3.26.1
Subsequent Events
6 Months Ended
Jun. 30, 2026
Subsequent Events [Abstract]  
Subsequent Events
(11) Subsequent Events
 
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements other than the restatement described in Note 2.
v3.26.1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2026
Trading Arrangements, by Individual [Table]  
Rule 10b5-1 Arrangement Adopted [Flag] false
Non-Rule 10b5-1 Arrangement Adopted [Flag] false
Rule 10b5-1 Arrangement Terminated [Flag] false
Non-Rule 10b5-1 Arrangement Terminated [Flag] false
v3.26.1
Restatement of Previously Issued Financial Statements (Tables)
6 Months Ended
Jun. 30, 2026
Restatement of Previously Issued Financial Statements [Abstract]  
Financial Statements - Restatement Reconciliation Tables
The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the periods indicated. The amounts in the "As Restated" columns are the updated amounts including the impacts from the restatement. Financial statement line items and subtotals that were not impacted by the restatement adjustments have been omitted for enhanced clarity.
 
Balance Sheet – as of December 31, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Deferred tax assets, net
 $-    $58,709   $58,709 
Total assets
  26,237,315    58,709    26,296,024 
                
Accrued expenses
  2,160,366    1,907,251    4,067,617 
Total current liabilities
  13,293,479    1,907,251    15,200,730 
Deferred tax liabilities, net
  355,646    (355,646    -  
Total liabilities
  13,883,222    1,551,605    15,434,827 
                
Accumulated deficit
  (18,054,278   (1,492,896   (19,547,174
Total stockholders’ equity
 $12,354,093   $(1,492,896  $10,861,197 
 
Statement of Operations – Three Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Selling, general, and administrative expenses  $2,627,168   $129,713   $2,756,881 
Total operating expenses   4,938,272    129,713    5,067,985 
Income from operations   121,270    (129,713   (8,443
Other income, net   179,684    (25,886   153,798 
Income before income taxes   300,954    (155,599   145,355 
Provision for income taxes   (71,427   61,513    (9,914
Net income   229,527    (94,086   135,441 
                
Net income per share – Basic and diluted  $0.02    (0.01  $0.01 
Statement of Operations - Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Selling, general, and administrative expenses
 $5,104,119   $266,308   $5,370,427 
Total operating expenses
  9,784,317    266,308    10,050,625 
Income from operations
  146,638    (266,308   (119,670
Other income, net
  360,516    (48,852   311,664 
Income before income taxes
  507,154    (315,160   191,994 
Provision for income taxes
  (118,565   54,203    (64,362
Net income
  388,589    (260,957   127,632 
                
Net income per share – Basic and diluted
 $0.04   $(0.03  $0.01 
 
Statements of Stockholders' Equity – Three Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Balance as of April 1, 2025
              
Accumulated deficit
 $(18,913,147  $(1,152,997  $(20,066,144
Total stockholders’ equity
  11,328,093    (1,152,997   10,175,096 
                
Balance as of June 30, 2025
              
Accumulated deficit
  (18,683,620   (1,247,083   (19,930,703
Total stockholders’ equity
 $11,677,738   $(1,247,083  $10,430,655 
 
Statements of Stockholders' Equity – Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Balance as of January 1, 2025
              
Accumulated deficit
 $(19,072,209  $(986,126  $(20,058,335
Total stockholders’ equity
  11,141,746    (986,126   10,155,620 
                
Balance as of June 30, 2025
              
Accumulated deficit
  (18,683,620   (1,247,083   (19,930,703
Total stockholders’ equity
 $11,677,738   $(1,247,083  $10,430,655 
Statement of Cash Flows –Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Six Months Ended June 30, 2025
              
Cash flows from operating activities:
              
Net income
 $388,589   $(260,957  $127,632 
Changes in operating assets and liabilities:
              
Accrued expenses
 $(263,634  $260,957   $(2,677
v3.26.1
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2026
Stockholders’ Equity [Abstract]  
Stock-based Compensation Expense for Stock Options
The table below summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three and six months ended June 30, 2026 and 2025, respectively, as follows:
 
                     
 
3 Months Ended
June 30,
 
6 Months Ended
June 30,
 
    2026     2025     2026     2025  
                     
Data and product costs
 $12,017   $9,541   $21,336   $18,000 
Selling, general and administrative expenses
  24,934    13,642    41,281    32,468 
                     
   $36,951   $23,183   $62,617   $50,468 
v3.26.1
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2026
Fair Value Measurements [Abstract]  
Cash and Cash Equivalents and Marketable Securities Measured at Fair Value on Recurring Basis
The tables below set forth the Company’s cash and cash equivalents, as well as marketable securities as of June 30, 2026 and December 31, 2025, respectively, which are measured at fair value on a recurring basis by level within the fair value hierarchy.
 
                     
 
June 30, 2026  
    Level 1     Level 2     Level 3     Total  
                     
Cash and cash equivalents
 $9,337,275   $   $   $9,337,275 
Held-to-maturity securities
  9,469,606            9,469,606 
   $18,806,881   $   $   $18,806,881 
 
                     
 
December 31, 2025  
    Level 1     Level 2     Level 3     Total  
                     
Cash and cash equivalents
 $6,248,223   $   $   $6,248,223 
Held-to-maturity securities
  12,615,881            12,615,881 
   $18,864,104   $   $   $18,864,104 
v3.26.1
Marketable Securities (Tables)
6 Months Ended
Jun. 30, 2026
Marketable Securities [Abstract]  
Cost and Fair Value of Marketable Securities
The tables below summarize the Company’s cost and fair value of marketable securities as of June 30, 2026 and December 31, 2025, respectively, as follows:
 
                
 
June 30, 2026  
    Amortized Cost     Gross Unrealized Gain     Fair Value  
Held-to-maturity securities
              
U.S. Treasury securities
 $9,469,606   $11,394   $9,481,000 
 
                
 
December 31, 2025  
    Amortized Cost     Gross Unrealized Gain     Fair Value  
Held-to-maturity securities
              
U.S. Treasury securities
 $12,615,881   $73,119   $12,689,000 
Maturities of Marketable Securities
Maturities of marketable securities as of June 30, 2026 and December 31, 2025, respectively, are as follows:
 
         
    June 30,
2026
    December 31,
2025
 
           
Held-to-maturity securities:
         
Due in one year or less
 $8,498,606   $10,618,881 
Due in 12 – 24 months
  971,000    1,997,000 
           
   $9,469,606   $12,615,881 
v3.26.1
Net Loss per Share (Tables)
6 Months Ended
Jun. 30, 2026
Net Loss per Share [Abstract]  
Computation of Basic and Diluted Net Income per Share
Basic net income per share is based on the weighted average number of common shares outstanding. Diluted net income per share is based on the weighted average number of common shares outstanding and the dilutive effect of outstanding stock options.
 
                     
 
3 Months Ended
June 30,
 
6 Months Ended
June 30,
 
    2026     2025     2026     2025  
                     
Weighted average common shares outstanding – basic
  10,767,501    10,767,501    10,767,501    10,744,826 
Potential shares exercisable under stock option plans
  -    311,673    -    312,731 
Less: Dilutive effect of outstanding stock option awards
  -    (226,100   -    (214,387
                     
Weighted average common shares outstanding – diluted
  10,767,501    10,853,074    10,767,501    10,843,170 
v3.26.1
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Financial Information of Reportable Segments The CODM makes operating decisions, assesses performance and allocates resources using the entity-wide revenue and expense information reported on the Condensed Statements of Operations and the more detailed significant expense categories disclosed in the table below. The primary measure of segment profit is net income as reported on the Condensed Statements of Operations.
                     
 
3 Months Ended
June 30,
 
6 Months Ended
June 30,
 
    2026

    2025
(As Restated)
    2026

    2025
(As Restated)
 
                     
Segment operating revenues
 $5,166,174   $5,059,542   $10,153,052   $9,930,955 
                     
Less: Significant segment expenses
                   
Data and product costs
                   
Employee expenses
  1,733,740    1,393,423    3,434,441    2,891,536 
Data feed expenses
  565,985    516,966    1,088,609    1,051,868 
Hosting and computer services expenses
  156,716    86,527    306,914    145,241 
Other data and product costs
  277,102    197,144    424,484    388,789 
Data and product costs subtotal
  2,733,543    2,194,060    5,254,448    4,477,434 
                     
Selling, general and administrative expenses
                   
Employee expenses
  1,858,260    1,932,924    3,727,046    3,847,035 
Professional fee expenses
  703,729    205,441    1,035,674    308,547 
Marketing expenses
  200,416    203,062    369,370    411,853 
Occupancy expenses (1)
  15,130    113,694    25,314    224,038 
Other general and administrative expenses
  267,261    301,760    515,029    578,954 
Selling, general and administrative expenses subtotal
  3,044,796    2,756,881    5,672,433    5,370,427 
                     
Other significant segment items
                   
Depreciation and amortization
  51,782    117,044    105,602    202,764 
Other (income), net
  (139,034   (153,798   (279,708   (311,664
(Benefit) provision for income taxes
  (50,124   9,914    (72,611   64,362 
                     
Segment net (loss) income
 $(474,789  $135,441   $(527,112  $127,632 
 
(1) Prior to the expiration of the Company’s leased office space on July 31, 2025, occupancy expenses included rent, utilities, repairs, and office supplies. Post expiration, occupancy expenses included the rental of virtual office space for Company meetings.
v3.26.1
Restatement of Previously Issued Financial Statements - Financial Statements - Restatement Reconciliation Tables (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Restatement of Previously Issued Financial Statements [Abstract]          
Deferred tax assets, net $ 58,709   $ 58,709   $ 58,709
Total assets 25,842,402   25,842,402   26,296,024
Accrued expenses 3,806,121   3,806,121   4,067,617
Total current liabilities 15,274,702   15,274,702   15,200,730
Total liabilities 15,445,700   15,445,700   15,434,827
Accumulated deficit (20,074,286) $ (19,930,703) (20,074,286) $ (19,930,703) (19,547,174)
Total stockholders’ equity 10,396,702 10,430,655 10,396,702 10,430,655 10,861,197
Selling, general, and administrative expenses 3,044,796 2,756,881 5,672,433 5,370,427  
Total operating expenses 5,830,121 5,067,985 11,032,483 10,050,625  
Income from operations (663,947) (8,443) (879,431) (119,670)  
Other income, net 139,034 153,798 279,708 311,664  
(Loss) income before income taxes (524,913) 145,355 (599,723) 191,994  
Provision for income taxes 50,124 (9,914) 72,611 (64,362)  
Net (loss) income $ (474,789) $ 135,441 $ (527,112) $ 127,632  
Net income per share – Basic (in Dollars per share) $ (0.04) $ 0.01 $ (0.05) $ 0.01  
Net income per share – diluted (in Dollars per share) $ (0.04) $ 0.01 $ (0.05) $ 0.01  
Accumulated deficit   $ (20,066,144) $ (19,547,174) $ (20,058,335)  
Balance $ 10,834,540 10,175,096 10,861,197 10,155,620  
Accumulated deficit (20,074,286) (19,930,703) (20,074,286) (19,930,703)  
Balance 10,396,702 10,430,655 10,396,702 10,430,655  
Cash flows from operating activities:          
Net income $ (474,789) 135,441 (527,112) 127,632  
Changes in operating assets and liabilities:          
Accrued expenses     (261,496) (2,677)  
As Previously Reported [Member]          
Restatement of Previously Issued Financial Statements [Abstract]          
Deferred tax assets, net         0
Total assets         26,237,315
Accrued expenses         2,160,366
Total current liabilities         13,293,479
Total liabilities         13,883,222
Accumulated deficit   (18,683,620)   (18,683,620) (18,054,278)
Total stockholders’ equity   11,677,738   11,677,738 12,354,093
Selling, general, and administrative expenses   2,627,168   5,104,119  
Total operating expenses   4,938,272   9,784,317  
Income from operations   121,270   146,638  
Other income, net   179,684   360,516  
(Loss) income before income taxes   300,954   507,154  
Provision for income taxes   (71,427)   (118,565)  
Net (loss) income   $ 229,527   $ 388,589  
Net income per share – Basic (in Dollars per share)   $ 0.02   $ 0.04  
Net income per share – diluted (in Dollars per share)   $ 0.02   $ 0.04  
Accumulated deficit   $ (18,913,147) (18,054,278) $ (19,072,209)  
Balance   11,328,093 12,354,093 11,141,746  
Accumulated deficit   (18,683,620)   (18,683,620)  
Balance   11,677,738   11,677,738  
Cash flows from operating activities:          
Net income   229,527   388,589  
Changes in operating assets and liabilities:          
Accrued expenses       (263,634)  
Adjustment [Member]          
Restatement of Previously Issued Financial Statements [Abstract]          
Deferred tax assets, net         58,709
Total assets         58,709
Accrued expenses         1,907,251
Total current liabilities         1,907,251
Total liabilities         1,551,605
Accumulated deficit   (1,247,083)   (1,247,083) (1,492,896)
Total stockholders’ equity   (1,247,083)   (1,247,083) (1,492,896)
Selling, general, and administrative expenses   129,713   266,308  
Total operating expenses   129,713   266,308  
Income from operations   (129,713)   (266,308)  
Other income, net   (25,886)   (48,852)  
(Loss) income before income taxes   (155,599)   (315,160)  
Provision for income taxes   61,513   54,203  
Net (loss) income   $ (94,086)   $ (260,957)  
Net income per share – Basic (in Dollars per share)   $ (0.01)   $ (0.03)  
Net income per share – diluted (in Dollars per share)   $ (0.01)   $ (0.03)  
Accumulated deficit   $ (1,152,997) (1,492,896) $ (986,126)  
Balance   (1,152,997) $ (1,492,896) (986,126)  
Accumulated deficit   (1,247,083)   (1,247,083)  
Balance   (1,247,083)   (1,247,083)  
Cash flows from operating activities:          
Net income   $ (94,086)   (260,957)  
Changes in operating assets and liabilities:          
Accrued expenses       $ 260,957  
Location, Statement of Financial Position, Balance [Axis]: us-gaap:DeferredIncomeTaxAssetsNet          
Restatement of Previously Issued Financial Statements [Abstract]          
Deferred tax liabilities, net         0
Location, Statement of Financial Position, Balance [Axis]: us-gaap:DeferredIncomeTaxAssetsNet | As Previously Reported [Member]          
Restatement of Previously Issued Financial Statements [Abstract]          
Deferred tax liabilities, net         355,646
Location, Statement of Financial Position, Balance [Axis]: us-gaap:DeferredIncomeTaxAssetsNet | Adjustment [Member]          
Restatement of Previously Issued Financial Statements [Abstract]          
Deferred tax liabilities, net         $ (355,646)
v3.26.1
Stockholders’ Equity (Details) - Stock Options [Member] - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Stockholders’ Equity [Abstract]        
Shares of common stock issued upon exercise of options (in Shares) 0   0 45,100
Exercise price (in Dollars per share)       $ 2.15
Proceeds from exercise of stock options       $ 96,935
Intrinsic value of stock options exercised   $ 20,325   $ 20,325
v3.26.1
Stockholders’ Equity - Stock-based Compensation Expense for Stock Options (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Stockholders’ Equity [Abstract]        
Stock-based compensation expense $ 36,951 $ 23,183 $ 62,617 $ 50,468
Location, Statement of Income, Balance [Axis]: us-gaap:OperatingCostsAndExpenses        
Stockholders’ Equity [Abstract]        
Stock-based compensation expense 12,017 9,541 21,336 18,000
Location, Statement of Income, Balance [Axis]: us-gaap:SellingGeneralAndAdministrativeExpense        
Stockholders’ Equity [Abstract]        
Stock-based compensation expense $ 24,934 $ 13,642 $ 41,281 $ 32,468
v3.26.1
Fair Value Measurements - Cash and Cash Equivalents and Marketable Securities Measured at Fair Value on Recurring Basis (Details) - Recurring [Member] - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Fair Value Measurements [Abstract]    
Cash and cash equivalents $ 9,337,275 $ 6,248,223
Held-to-maturity securities 9,469,606 12,615,881
Fair Value 18,806,881 18,864,104
Level 1 [Member]    
Fair Value Measurements [Abstract]    
Cash and cash equivalents 9,337,275 6,248,223
Held-to-maturity securities 9,469,606 12,615,881
Fair Value 18,806,881 18,864,104
Level 2 [Member]    
Fair Value Measurements [Abstract]    
Cash and cash equivalents 0 0
Held-to-maturity securities 0 0
Fair Value 0 0
Level 3 [Member]    
Fair Value Measurements [Abstract]    
Cash and cash equivalents 0 0
Held-to-maturity securities 0 0
Fair Value $ 0 $ 0
v3.26.1
Marketable Securities (Details) - USD ($)
6 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Marketable Securities [Abstract]    
Accrued bond interest receivable $ 93,964 $ 97,024
Other-than-temporary impairment loss $ 0  
v3.26.1
Marketable Securities - Cost and Fair Value of Marketable Securities (Details) - U.S. Treasury Securities [Member] - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Marketable Securities [Abstract]    
Amortized Cost $ 9,469,606 $ 12,615,881
Gross Unrealized Gain 11,394 73,119
Fair Value $ 9,481,000 $ 12,689,000
v3.26.1
Marketable Securities - Maturities of Marketable Securities (Details) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Held-to-maturity securities:    
Due in one year or less $ 8,498,606 $ 10,618,881
Due in 12 – 24 months 971,000 1,997,000
Held-to-maturity securities $ 9,469,606 $ 12,615,881
v3.26.1
Net Loss per Share (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2025
Stock Options [Member]    
Net Loss per Share [Abstract]    
Antidilutive securities excluded from computation of earnings per share (in Shares) 501,450 500,450
v3.26.1
Net Loss per Share - Computation of Basic and Diluted Net Income per Share (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Net Loss per Share [Abstract]        
Weighted average common shares outstanding – basic (in Shares) 10,767,501 10,767,501 10,767,501 10,744,826
Potential shares exercisable under stock option plans (in Shares)   311,673   312,731
Less: Dilutive effect of outstanding stock option awards (in Shares)   (226,100)   (214,387)
Weighted average common shares outstanding – diluted (in Shares) 10,767,501 10,853,074 10,767,501 10,843,170
v3.26.1
Segment Reporting (Details)
6 Months Ended
Jun. 30, 2026
Segment
Segment Reporting [Abstract]  
Number of operating segments 1
Number of reportable segments 1
v3.26.1
Segment Reporting - Segment Financial Information of Reportable Segments (Details) - Operating Segment [Member] - Single Reportable Segment [Member] - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Abstract]        
Segment operating revenues $ 5,166,174 $ 5,059,542 $ 10,153,052 $ 9,930,955
Data and product costs        
Employee expenses 1,733,740 1,393,423 3,434,441 2,891,536
Data feed expenses 565,985 516,966 1,088,609 1,051,868
Hosting and computer services expenses 156,716 86,527 306,914 145,241
Other data and product costs 277,102 197,144 424,484 388,789
Data and product costs subtotal 2,733,543 2,194,060 5,254,448 4,477,434
Selling, general and administrative expenses        
Employee expenses 1,858,260 1,932,924 3,727,046 3,847,035
Professional fee expenses 703,729 205,441 1,035,674 308,547
Marketing expenses 200,416 203,062 369,370 411,853
Occupancy expenses [1] 15,130 113,694 25,314 224,038
Other general and administrative expenses 267,261 301,760 515,029 578,954
Selling, general and administrative expenses subtotal 3,044,796 2,756,881 5,672,433 5,370,427
Other significant segment items        
Depreciation and amortization 51,782 117,044 105,602 202,764
Other (income), net (139,034) (153,798) (279,708) (311,664)
(Benefit) provision for income taxes (50,124) 9,914 (72,611) 64,362
Net (loss) income $ (474,789) $ 135,441 $ (527,112) $ 127,632
[1] Prior to the expiration of the Company’s leased office space on July 31, 2025, occupancy expenses included rent, utilities, repairs, and office supplies. Post expiration, occupancy expenses included the rental of virtual office space for company meetings.